Vertex Pharmaceuticals (NASDAQ:VRTX) reports third-quarter results on Nov. 2. Cystic fibrosis still pays the bills, but I’ll ...

AI is transforming organizational structures, and a lawful restructuring is not a lawsuit. But some companies have discovered ...

QAOA builds then sheds entanglement during optimisation, a behaviour markedly different from FALQON which peaks much later in ...

Vertex stock popped Tuesday — while shares of rival Maze Therapeutics (MAZE) skyrocketed — on a surprise expansion for their kidney disease drugs. Both companies are working on treatments for ...

Vertex plans to discuss the data with regulators in the context of the pivotal Amplitude trial. (Joseph Prezioso/AFP/Getty Images) Vertex has reported positive phase 2b data for its kidney disease ...

Vertex Pharmaceuticals' core business is rock-solid, but it is also slowly expanding into new areas. The company should see improved top-line growth over the next few years, driven by new launches.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Akira lives a peaceful life with his older sister Haruka and his mother, who runs a cafe. The family, however, harbors a secret — Haruka has inherited a power from her father called "Engine," and she ...

Vertex Pharmaceuticals appears likely to continue to dominate its core therapeutic area. The company is slowly developing and launching medicines in other markets. However, for now, Vertex continues ...

Across 101 enterprises, the infrastructure that feeds AI agents their business context is being built faster than it can be trusted. Retrieval-augmented generation is already the default context ...

Formula One fans affected by the loose drain cover fiasco at the 2023 Las Vegas Grand Prix are now one step closer to being monetarily compensated for their troubles. F1 leadership agreed to dole out ...

Yesterday, July 6th, the San Diego, California-based biotech Crinetics Pharmaceuticals, Inc. (CRNX) announced that it was set to be acquired by Boston-based Pharma giant Vertex Pharmaceuticals ...